Europe Network Point-of-care Glucose Testing Market Size & Outlook
Europe network point-of-care glucose testing market, 2016-2028 (US$M)
Related Markets
Europe network point-of-care glucose testing market highlights
- The Europe network point-of-care glucose testing market generated a revenue of USD 360.5 million in 2021.
- The market is expected to grow at a CAGR of 3.6% from 2022 to 2028.
- In terms of segment, accu-chek inform ii was the largest revenue generating types in 2021.
- CareSens Expert Plus is the most lucrative types segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2022 to 2028.
Europe data book summary
| Market revenue in 2021 | USD 360.5 million |
| Market revenue in 2028 | USD 461.3 million |
| Growth rate | 3.6% (CAGR from 2021 to 2028) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.1% of the global network point-of-care glucose testing market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 385.1 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 48.4% in 2021. Horizon Databook has segmented the Europe network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
Rising burden of diabetes along with increasing demand for rapid diagnostic tools for diabetes management in the region is a key factor driving the Europe POC glucose testing market.
Local players in Europe have diverse product portfolios, which has significantly contributed to its revenue in 2019. For instance, HemoCue AB is a POC diagnostics company, situated in Sweden, offering POC testing solutions for better management of diabetes.
Reasons to subscribe to Europe network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe network point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe network point-of-care glucose testing market size, by country, 2016-2028 (US$M)
Europe Network Point-of-Care Glucose Testing Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
